MENU
TVGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tevogen Bio Holdings (TVGN) Ownership - Who owns Tevogen Bio Holdings?
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (“CD8+ CTLs†or “CTLsâ€), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders... Show more
Profile
Industry
N/A
Address
15 Independence Boulevard
Phone
N/A
Employees
N/A
Web
https://www.tevogen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
187.57M
P/E Ratio
2.88
Total Cash
2.33M
Projected Growth
N/A
Total Debt
2.96M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TVGN
Capitalization
188M
P/E Ratio
2.88
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
2.33M
Total Cash/Share
0.01
Total Debt
2.97M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-12.99M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.35
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17.1K
Current Ratio
0.34
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
52.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
1303.51
Shares Held By Institutions
4.55M
Shares Outstanding - Current
184M
Total Liabilities
10.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-1.942
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
15 Independence Boulevard
Phone
N/A
Employees
N/A
Web
https://www.tevogen.com